Robert W. Baird Issues Pessimistic Forecast for Global Medical REIT (NYSE:GMRE) Stock Price

Global Medical REIT (NYSE:GMREGet Free Report) had its price target reduced by equities research analysts at Robert W. Baird from $10.00 to $9.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 31.77% from the company’s previous close.

Separately, B. Riley started coverage on shares of Global Medical REIT in a report on Thursday, April 3rd. They set a “neutral” rating and a $9.00 price target on the stock.

Read Our Latest Analysis on GMRE

Global Medical REIT Trading Down 1.6 %

Shares of NYSE GMRE opened at $6.83 on Thursday. The stock has a market capitalization of $456.73 million, a P/E ratio of -341.33, a PEG ratio of 1.43 and a beta of 1.23. Global Medical REIT has a 1-year low of $6.75 and a 1-year high of $10.46. The business’s 50 day moving average is $8.00 and its two-hundred day moving average is $8.23. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28.

Global Medical REIT (NYSE:GMREGet Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $34.60 million for the quarter, compared to analyst estimates of $35.49 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. As a group, research analysts expect that Global Medical REIT will post 0.81 EPS for the current year.

Hedge Funds Weigh In On Global Medical REIT

A number of hedge funds have recently added to or reduced their stakes in GMRE. Quarry LP boosted its holdings in shares of Global Medical REIT by 111.5% in the fourth quarter. Quarry LP now owns 4,940 shares of the company’s stock valued at $38,000 after purchasing an additional 2,604 shares during the period. PNC Financial Services Group Inc. grew its position in shares of Global Medical REIT by 58.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,260 shares of the company’s stock worth $48,000 after buying an additional 2,301 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Global Medical REIT by 11,234.4% during the first quarter. GAMMA Investing LLC now owns 7,254 shares of the company’s stock valued at $63,000 after buying an additional 7,190 shares during the period. Squarepoint Ops LLC bought a new stake in shares of Global Medical REIT in the fourth quarter valued at about $82,000. Finally, Corton Capital Inc. purchased a new stake in Global Medical REIT in the fourth quarter worth about $85,000. 57.52% of the stock is currently owned by institutional investors.

Global Medical REIT Company Profile

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Articles

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.